Skip to main content
Devonian Health Group Inc logo

Devonian Health Group Inc — Investor Relations & Filings

Ticker · GSD ISIN · CA2518341078 TSXV Manufacturing
Open in API
Filings indexed 598 across all filing types
Latest filing 2020-02-18 Regulatory Filings
Country CA Canada
Listing TSXV GSD

About Devonian Health Group Inc

https://groupedevonian.com/

Devonian Health Group Inc. is a clinical-stage botanical pharmaceutical company specializing in the development of novel prescription therapeutic solutions for unmet medical needs. The core business involves late-stage prescription botanical drugs targeting fibroinflammatory autoimmune diseases, with a focus on gastrointestinal, dermatological, and hepatologic conditions. The company utilizes a broad-based technology platform, originating from over 20 years of research, to develop therapies that target multiple cellular pathways and regulate genes linked to these diseases. Its pipeline includes the lead product candidate, Thykamine, currently in Phase 3 clinical trials. Devonian also develops high-value dermatological products alongside its core drug development activities.

Recent filings

Filing Released Lang Actions
Report of exempt distribution excluding schedule 1 of Form 5.pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 52-109F1 Certification of Annual Filings by the CEO of Emera Inc. It certifies the review and fair presentation of the annual filings including the annual financial statements and MD&A for the fiscal year ended December 31, 2019. The content is primarily an officer certification regarding the accuracy and completeness of the annual filings and the design and evaluation of disclosure controls and internal controls over financial reporting. There are no actual financial statements or substantive financial data presented in this document itself. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than as the Annual Report (10-K) or other financial reports. The document length is about 5204 characters, which is sufficient for a certification but does not contain the full report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-02-18 English
Material change report - French.pdf
Regulatory Filings
2020-02-11 English
News release - English.pdf
Regulatory Filings
2020-02-11 English
Report of exempt distribution excluding schedule 1 of Form 5.pdf
Regulatory Filings Classification · 100% confidence The document is titled 'Form 45-106F1 Report of Exempt Distribution' and contains detailed instructions and fields related to filing reports of exempt distributions in Canadian jurisdictions. It includes regulatory references to Canadian securities laws and filing requirements for issuers and underwriters. The content is a regulatory form used for reporting exempt distributions of securities, not a financial report, earnings release, or management discussion. It is a specific regulatory filing form used to comply with securities regulations, which fits best under the category of Regulatory Filings (RNS). The document is lengthy and detailed, indicating it is the form itself, not just an announcement of a report publication.
2020-01-29 English
News release - French.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a press release announcing two main items: the issuance of securities in settlement of interest owed to a debenture holder, and the results of the Annual General Meeting (AGM) of shareholders. The AGM results include the election of directors, ratification of the stock option plan, and appointment of the external auditor. The document contains detailed voting results and corporate governance decisions made at the AGM. It does not contain full financial statements or detailed financial performance data typical of an Annual Report or Interim Report. It also is not a simple announcement of a report publication but a substantive disclosure of AGM outcomes and related corporate actions. Therefore, the document fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results from the AGM.
2020-01-29 English
News release - English.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document contains two main parts: first, an announcement about the issuance of securities to a debenture holder as payment of interest, which involves related party transactions and regulatory compliance under Regulation 61-101. This is a capital/financing activity. Second, it announces the results of the Annual General Meeting (AGM) of shareholders, including election results for the Board of Directors, appointment of auditors, and ratification of the stock option plan. The document is a press release-type announcement combining a capital/financing update and AGM results. Since it includes official results from shareholder votes at the AGM, the classification should be Declaration of Voting Results & Voting Rights Announcements (DVA). The issuance of securities is also a financing update, but the primary focus and title emphasize the AGM results and voting outcomes. The document length (7462 characters) and content indicate it is not merely a report publication announcement but a substantive announcement of voting results and related financing update. Given the prominence of AGM results and voting outcomes, the best fit is DVA with high confidence.
2020-01-29 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.